Director, Field Reimbursement Lead - East

This role is considered Virtual.OverviewWe are seeking a Director, Field Reimbursement Lead - East to manage a regional team of field reimbursement directors. The Field Reimbursement Team is a critical component of the commercial strategy and will work in close collaboration with Sales, Patient Services, Strategic Account Management and Market Access to support Alnylam's patient-focused vision of harnessing a revolution in biology for human health.This field-based position will report to the Senior Director, Field Reimbursement and requires 50-75% travel.The successful candidate must be passionate about science and deeply motivated by the quest of delivering value to patients with the long-term success of the company in mind. This individual will have a deep and board understanding of access and reimbursement across the healthcare landscape, as well as cross-functional business knowledge to optimize access and deliver an excellent customer experience.Key ResponsibilitiesHire, lead, and empower an experienced and talented team of field reimbursement directors skilled in access, coverage, and reimbursement across all sites of care including physician office, ambulatory infusion center, hospital outpatient department and home treatmentFoster and inspire a collaborative, inclusive and high-performing team culture that encourages accountability and embraces innovation with a purposeful sense of urgencyProvide regular performance feedback, coaching and professional development to team membersPartner with the Senior Director, Field Reimbursement in the development of strategy, tactics and messaging that align to Market Access priorities as well as in the creation of key performance metricsUtilize analytics and reporting dashboards to identify access and reimbursement issues within the region and collaborate closely with leadership from Sales, Patient Services, Strategic Account Management, and Market Access in the development of strategic solutions and action plansDeliver consistent guidance via team calls, field ride alongs, and meeting engagements to ensure the team is compliantly and effectively leveraging tools and materials to educate healthcare professionalsServe as the escalation point for regional access and reimbursement challengesMaintain strategic relationships with Medicare Administrative Contractors (MACs) within the region to ensure optimal coverage for Alnylam therapies and monitor Local Coverage Determinations (LCDs) and National Coverage Determinations (NCDs)Ensure team's compliance with the appropriate ways of working across diverse cross-functional partnershipsQualificationsBachelor's degree required10+ years of pharmaceutical/biotech experience required8+ years of field reimbursement experience within a 'buy and bill' environment required3+ years of leading a field reimbursement team or experience managing a field- based team preferredIn-depth knowledge of both medical benefit and pharmacy benefit across all payer types (Medicare, Medicaid, commercial and VA/DoD) and sites of care (physician office, ambulatory infusion center, hospital outpatient department and home treatment)Established relationships with Medicare Administrative Contractors (MACs) highly preferredProven ability to identify key access and reimbursement barriers to treatment and design effective resolution plansDemonstrated ability to work in a highly collaborative matrixDesire to work in a fast-paced, energetic environmentSelf-starter who is enthusiastic about rare disease and Alnylam's core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to peopleMust reside in or live in close proximity to designated area of responsibilityAbout Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients.>